Search Results for keywords:"regulatory freeze"

The General Services Administration (GSA) announced a delay in implementing certain amendments to its acquisition regulations, initially published on December 27, 2024. This postponement aligns with a Presidential Memorandum from January 20, 2025, which called for a regulatory freeze for review. The affected regulations' effective date has been moved from January 2025 to May 2025. This change is officially recorded in the Federal Register with document number 2025-05430.

The Centers for Medicare & Medicaid Services from the Department of Health and Human Services is delaying the effective date of a new rule concerning Medicare Part D. Originally set to take effect on February 1, 2021, the rule will now start on March 30, 2021. This delay follows a Presidential memorandum on January 20, 2021, aiming to freeze new regulations for 60 days. The rule in question will establish a new electronic standard for how prescribers and insurers manage authorizations for prescription drugs under Medicare Part D.

The Office of Workers' Compensation Programs (OWCP) is withdrawing a direct final rule published on December 14, 2020, which proposed changes to regulations on electronic filing, settlements, and penalties under the Longshore and Harbor Workers' Compensation Act. This action aligns with a January 20, 2021, memorandum from the Assistant to the President and Chief of Staff aiming for a regulatory review by the new administration. The withdrawal provides the administration time for assessment and may invite further public comments later.

The U.S. Department of Transportation (DOT) announced they will delay enforcement of a rule about safe accommodations for air travelers with disabilities using wheelchairs. This enforcement delay is until March 20, 2025, to allow time for further review and to ensure compliance with administrative policies. The final rule, which was initially published on December 17, 2024, aims to address issues related to mishandled wheelchairs and improper transfers on aircraft. The DOT is taking this step in response to a presidential directive for reviewing new rules.

The Office of Workers' Compensation Programs (OWCP) has decided to withdraw a notice and request for comments about self-insurance under the Black Lung Benefits Act that was initially published on January 8, 2021. This decision is due to changes in the legal rules and guidance that initially justified the publication. Although the notice has been withdrawn, there's no change to existing laws or regulations. OWCP plans to review the self-insurance bulletin and will allow the public to comment on self-insurance procedures at a future date.

The General Services Administration (GSA) is delaying the start of certain regulation changes, which were initially published on December 27, 2024, and planned to take effect in January 2025. This 60-day postponement ensures compliance with a Presidential Memorandum issued by President Donald J. Trump, which called for a regulatory freeze pending review. The regulation updates will now become effective on March 27, 2025.

The Food and Drug Administration (FDA) issued a rule regarding nonprescription drugs that require additional conditions for safe use. Originally set to take effect on January 27, 2025, the rule has been delayed twice and is now effective on May 27, 2025, due to a review process triggered by a presidential memorandum. The new rule establishes specific requirements for drug applications, labeling, and reporting related to these nonprescription drugs. The FDA intends to use this extra time for a thorough review, as immediate public input was deemed impractical and potentially against public interests, to ensure that entities affected by the rule have sufficient time to adjust their compliance strategies.

The Environmental Protection Agency (EPA) is delaying the start date of four regulations that were published between November 29, 2024, and December 31, 2024, until March 21, 2025. This decision aligns with a memorandum from President Donald J. Trump issued on January 20, 2025, instructing federal agencies to temporarily postpone new rules so they can be reviewed. The delay is intended to give officials more time to assess these regulations and was enacted immediately without public input, based on legal exceptions that allow such an action. The EPA may consider further extensions of these regulations' effective dates in the future.

The Animal and Plant Health Inspection Service (APHIS) has postponed the removal of an exemption that allowed small commercial passenger aircraft to avoid paying certain user fees related to agricultural quarantine and inspection (AQI) services. This delay, effective until June 2, 2025, is due to a regulatory freeze for review. APHIS is seeking public input on whether these small aircraft pose a lesser risk than larger aircraft and if they merit reduced fees. Feedback is also requested on how AQI fees can be structured differently based on risk and service levels.

On January 6, 2025, the U.S. Department of Housing and Urban Development (HUD) had planned to implement updates to the HOME Investment Partnerships Program on February 5, 2025. However, following a presidential directive for regulatory review, HUD initially delayed this to April 20, 2025. HUD now announces further delays for certain parts of the program: one key provision is delayed until October 30, 2025, while another is withdrawn, with other sections remaining scheduled for the original April date. These changes are meant to allow more time for public input and to ensure compliance with existing laws.